ABOUT
BiolMed is an innovation driven biomedical products company. We develop and manufacture bioabsorbable implants for soft and hard tissue repair and also non-adherent wound dressings.
ABOUT
News
BiolMed completes first round of angel investment
Dec 2019: BIOLMED has completed its first round of angel investment. The round will accelerate product development of Serioss, Serimat and Easypeel and contribute towards setting up of pilot manufacturing facility.
BiolMed receives the DBT-BIRAC-SBIRI grant funding
Feb 2019: Biotechnology Industry Research Assistance Council (BIRAC) approved the SBIRI funding for the second product - Serimat. The funding approved is to the tune of INR 89 Lakhs. The funding will accelerate the preclinical validation of Serimat.
BiolMed receives the DBT-BIRAC-BIPP grant funding
Feb 2018: Biotechnology Industry Research Assistance Council (BIRAC) approved the BIPP funding for the flagship product of BiolMed - Serioss. The funding approved is to the tune of 1.5 Cr. The funding will accelerate the product development path for Serioss.
BIRAC awards SBIRI grant to BiolMed Innovations
Feb 2017: Biotechnology Industry Research Assistance Council (BIRAC) approved the funding for SBIRI for the second product that the company is developing. The company was approved funding of ₹ 24.96 Lakhs. The funding will support the development of a composite matrix for soft tissue reconstruction.
BiolMed wins the prestigious Biotechnology Ignition Grant from DBT-BIRAC
June 2015: Biotechnology Industry Research Assistance Council (BIRAC) approved the funding for BiolMed Innovations in the fourth round for the Biotechnology Ignition Grant (BIG). The company was approved funding of ₹ 49.26 Lakhs. The funding will support the initial set up for the first product development for BiolMed.